Dow Down 0.17% Nasdaq Down 0.28%

Agenus Inc. (AGEN)

-NasdaqCM
3.11 Down 0.02(0.64%) Sep 30, 4:00PM EDT
Prev Close:3.13
Open:3.13
Bid:1.90 x 400
Ask:3.13 x 700
1y Target Est:6.00
Beta:2.16
Next Earnings Date:N/A
Day's Range:3.10 - 3.22
52wk Range:2.27 - 5.27
Volume:626,069
Avg Vol (3m):688,245
Market Cap:194.93M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 0.64%194.93M
ABPI 0.00%134.63K
DNDNDown 5.26%223.82M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback